{
  "case_id": "case_0024",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 45.82,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "Middle Eastern / North African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- right optic nerve (cranial nerve II).\n  \nMore precision is possible than: 'right thoracic spinal cord'.  \nNamely: right T5 spinal cord.\n  \nAdditional signs indicate potential further lesion in:\n- left optic nerve (cranial nerve II).",
      "structured_data": {
        "gt_lesions_english": [
          "right T5 myelopathy",
          "left optic nerve (cranial nerve II)",
          "right optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "thoracic spinal cord",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "optic nerve",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [
          [
            "right thoracic spinal cord",
            "right T5 myelopathy"
          ]
        ],
        "missing_lesions_from_ft": [
          "left optic nerve (cranial nerve II)"
        ],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 3,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 1,
        "missed_lesion_count": 1,
        "additional_lesion_count": 0,
        "proportion_correct": 0.3333333333333333,
        "proportion_imprecise": 0.3333333333333333,
        "proportion_missed": 0.3333333333333333,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Neuromyelitis optica spectrum disorder (AQP4-IgG positive); MOG antibody\u2013associated disease; Compressive thoracic cord lesion (disc/meningioma/epidural pathology); Idiopathic transverse myelitis; Spinal cord sarcoidosis; Vitamin B12 deficiency (subacute combined degeneration); Neurosyphilis",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing\u2013remitting multiple sclerosis",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "MOG antibody\u2013associated disease",
          "Compressive thoracic cord lesion (disc/meningioma/epidural pathology)",
          "Idiopathic transverse myelitis",
          "Spinal cord sarcoidosis",
          "Vitamin B12 deficiency (subacute combined degeneration)",
          "Neurosyphilis"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Astigmatism": "comorbidity",
          "Caesarean section": "comorbidity",
          "Perimenopause": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Astigmatism",
          "Caesarean section",
          "Perimenopause"
        ],
        "additional_diagnoses": [
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "MOG antibody\u2013associated disease",
          "Compressive thoracic cord lesion (disc/meningioma/epidural pathology)",
          "Idiopathic transverse myelitis",
          "Spinal cord sarcoidosis",
          "Vitamin B12 deficiency (subacute combined degeneration)",
          "Neurosyphilis"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Orbits and Thoracic Spine and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and entire spine with gadolinium",
          "MRI of orbits with gadolinium",
          "Lumbar puncture: CSF cell count and differential",
          "CSF protein and glucose",
          "CSF oligoclonal bands with paired serum",
          "Serum aquaporin-4 IgG (cell-based assay)",
          "Serum MOG IgG (cell-based assay)",
          "Visual evoked potentials",
          "Optical coherence tomography of optic nerves",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "Blood glucose",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Thyroid function tests",
          "Vitamin B12",
          "Folate",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel (including SSA/SSB)",
          "Double-stranded DNA antibody",
          "Serum ACE",
          "HIV 1/2 antigen/antibody",
          "Syphilis serology (treponemal test and RPR)",
          "Hepatitis B surface antigen",
          "Hepatitis B core antibody",
          "Hepatitis C antibody",
          "Quantiferon-TB Gold",
          "Serum 25-hydroxy vitamin D",
          "Pregnancy test"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 3,
        "found_tests_count": 3,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- No indication this isn't an exacerbation of an old deficit/pseudorelapse.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute inflammatory myelitis suspected",
              "Early steroids improve recovery",
              "Start immediately after urgent MRI excludes compressive/infective lesion"
            ]
          },
          {
            "treatment": "Proton pump inhibitor",
            "timing": "Start Now",
            "reasons": [
              "Gastric protection during high-dose corticosteroids"
            ]
          },
          {
            "treatment": "Venous thromboembolism prophylaxis (LMWH and compression stockings)",
            "timing": "Start Now",
            "reasons": [
              "Reduced mobility",
              "Prevention of DVT/PE"
            ]
          },
          {
            "treatment": "Physiotherapy and gait rehabilitation",
            "timing": "Start Now",
            "reasons": [
              "Improve mobility and balance",
              "Prevent deconditioning and falls"
            ]
          },
          {
            "treatment": "Plasma exchange (5\u20137 sessions)",
            "timing": "Delay",
            "reasons": [
              "Use if inadequate response to steroids within days",
              "Particularly effective in NMOSD or severe relapse"
            ]
          },
          {
            "treatment": "Disease-modifying therapy for multiple sclerosis (e.g., ocrelizumab/high-efficacy agent)",
            "timing": "Delay",
            "reasons": [
              "Initiate after diagnostic confirmation and counselling",
              "Requires infection screening and vaccinations"
            ]
          },
          {
            "treatment": "Rituximab-based therapy for AQP4-positive NMOSD",
            "timing": "Delay",
            "reasons": [
              "Only if AQP4-IgG positive/NMOSD confirmed",
              "Start after acute attack management"
            ]
          },
          {
            "treatment": "Urgent neurosurgical decompression",
            "timing": "Delay",
            "reasons": [
              "Only indicated if MRI shows compressive thoracic cord lesion",
              "Not appropriate for inflammatory demyelination"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute inflammatory myelitis suspected",
              "Early steroids improve recovery",
              "Start immediately after urgent MRI excludes compressive/infective lesion"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- No indication this isn't an exacerbation of an old deficit/pseudorelapse.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-modifying therapy for multiple sclerosis (e.g., ocrelizumab/high-efficacy agent)",
            "timing": "Delay",
            "reasons": [
              "Initiate after diagnostic confirmation and counselling",
              "Requires infection screening and vaccinations"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 2,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.3333333333333333,
          "proportion_reasons_missed": 0.6666666666666666
        }
      }
    }
  }
}